William M Pardridge
Pardridge, William M.
VIAF ID: 59156282 (Personal)
Permalink: http://viaf.org/viaf/59156282
Preferred Forms
- 200 _ | ‡a Pardridge ‡b William M.
-
-
- 100 1 0 ‡a Pardridge, William M.
-
- 100 1 _ ‡a Pardridge, William M.
- 100 1 _ ‡a Pardridge, William M.
-
-
- 100 1 _ ‡a Pardridge, William M.
- 100 0 _ ‡a William M Pardridge
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Brain drug targeting : the future of brain drug development | |
Effects of human serum on transport of testosterone and estradiol into rat brain | |
Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein. | |
Enhanced endocytosis and anti-human immunodeficiency virus type 1 activity of anti-rev antibodies after cationization. | |
Enhanced endocytosis in cultured human breast carcinoma cells and in vivo biodistribution in rats of a humanized monoclonal antibody after cationization of the protein. | |
Enhanced GLUT1 glucose transporter and cytoskeleton gene expression in cultured bovine brain capillary endothelial cells after treatment with phorbol esters and serum | |
Enhanced hepatic extraction of estrogens used for replacement therapy. | |
Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector | |
Enhanced uptake of rsCD4 across the rodent and primate blood-brain barrier after conjugation to anti-transferrin receptor antibodies. | |
Enzymatic barrier protects brain capillaries from leukotriene C4. | |
Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector | |
Evidence for translational control elements within the 5'-untranslated region of GLUT1 glucose transporter mRNA. | |
Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier | |
Formulation of therapeutic synthetic polymers for drug and gene delivery ▾ | |
Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation | |
Gene targeting in vivo with pegylated immunoliposomes | |
Gene therapy of the brain: the trans-vascular approach | |
Genetic engineering of a bifunctional IgG fusion protein with iduronate-2-sulfatase. | |
Genetically engineered brain drug delivery vectors: cloning, expression and in vivo application of an anti-transferrin receptor single chain antibody-streptavidin fusion gene and protein. | |
Global non-viral gene transfer to the primate brain following intravenous administration. | |
Glucose and amino acid metabolism in neonatal rat skeletal muscle in tissue culture | |
Glucose deprivation and hypoxia increase the expression of the GLUT1 glucose transporter via a specific mRNA cis-acting regulatory element | |
Glucose transport and phosphorylation: which is rate limiting for brain glucose utilization? | |
GLUT-1 glucose transporter is present within apical and basolateral membranes of brain epithelial interfaces and in microvascular endothelia with and without tight junctions. | |
GLUT1 glucose transporter: differential gene transcription and mRNA binding to cytosolic and polysome proteins in brain and peripheral tissues. | |
Hepatic Bioavailability of Serum Thyroid Hormones in Nonthyroidal Illness* | |
Hepatic bioavailability of thyroxine and testosterone in familial dysalbuminemic hyperthyroxinemia. | |
High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium | |
High molecular weight Alzheimer's disease amyloid peptide immunoreactivity in human serum and CSF is an immunoglobulin G. | |
hnRNP A2 and hnRNP L bind the 3'UTR of glucose transporter 1 mRNA and exist as a complex in vivo | |
Hormonal effects of danazol and medical oophorectomy in endometriosis | |
Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels | |
Human brain microvascular DR-antigen | |
Human LAT1 single nucleotide polymorphism N230K does not alter phenylalanine transport | |
Hypoxia induces de-stabilization of the LAT1 large neutral amino acid transporter mRNA in brain capillary endothelial cells | |
IgG-paraoxonase-1 fusion protein for targeted drug delivery across the human blood-brain barrier | |
IgG-single chain Fv fusion protein therapeutic for Alzheimer's disease: Expression in CHO cells and pharmacokinetics and brain delivery in the rhesus monkey | |
Imaging amyloid plaque in Alzheimer's disease brain with a biotinylated Aβ peptide radiopharmaceutical conjugated to an IgG-avidin fusion protein | |
Imaging brain tumors by targeting peptide radiopharmaceuticals through the blood-brain barrier. | |
Imaging gene expression in the brain in vivo in a transgenic mouse model of Huntington's disease with an antisense radiopharmaceutical and drug-targeting technology. | |
Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy. | |
Immunohistochemical study of cerebral amyloid angiopathy: use of an antiserum to a synthetic 28-amino-acid peptide fragment of the Alzheimer's disease amyloid precursor. | |
Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease | |
Impermeability of the rat blood-brain barrier to exogenously administered gonadotropin-releasing hormone | |
In vivo availability of circulating estradiol in postmenopausal women with and without endometrial cancer. | |
In vivo cleavability of a disulfide-based chimeric opioid peptide in rat brain. | |
In vivo demonstration of subcellular localization of anti-transferrin receptor monoclonal antibody-colloidal gold conjugate in brain capillary endothelium | |
In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats. | |
In vivo quantification of receptor-mediated uptake of asialoglycoproteins by rat liver. | |
Increased blood--brain barrier transport of protein-bound anticonvulsant drugs in the newborn. | |
Influence of blood components on the tissue uptake indices of cyclosporin in rats. | |
Influx of testosterone-binding globulin (TeBG) and TeBG-bound sex steroid hormones into rat testis and prostate | |
Influx of thyroid hormones into rat liver in vivo. Differential availability of thyroxine and triiodothyronine bound by plasma proteins | |
Inhibition by indomethacin of increased estradiol extraction by the IUD-containing rat uterine horn | |
Inorganic mercury: selective effects on blood-brain barrier transport systems. | |
Insulin binding to the blood-brain barrier in the streptozotocin diabetic rat. | |
Insulin receptor antibody-iduronate 2-sulfatase fusion protein: pharmacokinetics, anti-drug antibody, and safety pharmacology in Rhesus monkeys | |
Insulin receptor antibody-sulfamidase fusion protein penetrates the primate blood-brain barrier and reduces glycosoaminoglycans in Sanfilippo type A cells | |
Insulin therapy normalizes GLUT1 glucose transporter mRNA but not immunoreactive transporter protein in streptozocin-diabetic rats. | |
Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter | |
Introduction to the blood-brain barrier : methodology, biology, and pathology | |
Peptide drug delivery to the brain |